<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
        <title>Principles of Inflammation III</title>
        <meta name="viewport" content="width=device-width">

        <!-- syntax highlighting CSS -->
        <link rel="stylesheet" href="/css/syntax.css">

        <!-- Custom CSS -->
        <link rel="stylesheet" href="/css/main.css">

		<!-- Set refresh timer for local development 
		<meta http-equiv="refresh" content="10" />-->
		
    </head>
    <body>

        <div class="container">
          <div class="site">

			<h1>Principles of Inflammation III</h1>
			<p class="meta">04 Feb 2014</p>

			<div class="post">
			<h3 id="what-reverses-inflammation">What reverses inflammation?</h3>
<ul>
  <li>eNO reduces rolling and adhesion</li>
  <li>IL-10 inhibits TNF, gamma-interferon, IL-2, and IL-3</li>
  <li>Neutrophilic <strong>pyrin</strong>: stops IL-1 production. How? Typically, a protein complex called the inflammasome activates proteases like Caspase-1, which activates IL-1. Pyrin blocks caspase-1 activation, thus preventing IL-1 activation.</li>
  <li><strong>Lipoxins</strong> from lipo-oxygenase pathway: derived from arachidonic acid, most made from LTA<sub>4</sub>, but sometimes can be pro-inflammatory. Functions by inhibiting leukotriene synthesis, reducing WBC adhesion, and PMN chemotaxis</li>
</ul>

<p><span><br /></span></p>

<h3 id="anti-inflammatory-drugs">Anti-inflammatory drugs</h3>
<ul>
  <li><strong>Antihistamines</strong>: diphenhydramine</li>
  <li><strong>Antibodies</strong> to adhesion molecules: natalizumab, anti-alpha4-integrin. Clinical trials ongoing for use in multiple sclerosis</li>
  <li><strong>Antibodies to complement</strong>: eculizumab, anti-C5 antibody, inhibits MAC formation</li>
  <li><strong>Anti-TNF agents</strong>: etanercept, blocks TNF, used in rheumatoid arthritis</li>
  <li><strong>Anti-purine signaling</strong>: clopidogrel, inhibits platelets P2X/Y receptors.</li>
  <li><strong>Corticosteroids</strong>: block arachidonic acid synthesis, modulate phospholipase A<sub>2</sub> activity</li>
  <li><strong>Non-steroidal anti-inflammatories (NSAIDs)</strong>: inhibit COX-1 and/or COX-2.</li>
  <li><strong>Anti-leukotriene drugs</strong>: 5-lipoxygenase inhibitors, FLAP inhibitors, leukotriene receptor antagonists (montelukast).</li>
</ul>

<p><span><br /></span></p>

<h3 id="inflammation---morphology-and-temporality">Inflammation - Morphology and Temporality</h3>
<ul>
  <li><strong>Acute, short-duration</strong>: PMNs predominate, with classic signs of inflammation (rubor, calorâ€¦). Histological samples showing acute inflammation show lots and lots of PMNs, sometimes with identifiable macrophages. <em>Outcomes</em>: optimally: resolution or repair, less optimally: scar formation (fibrosis), other possibilities: abscess formation, chronic inflammation.</li>
  <li><strong>Subacute-intermediate duration</strong>: polymorphous, mixed infiltrate with granulation tissue (see next lecture!). Histological samples showing subacute inflammation have a more diverse mixture of PMNs, lymphocytes, and macrophages. </li>
  <li><strong>Chronic or long-duration</strong>: no PMNs, no rubor, no calor. More advanced healing with collagen. Mediated by CD34:L-selectin and VCAM-1:VLA4 interactions of endothelial cell and leukocytes.</li>
  <li><strong>Chronic granulomatous inflammation</strong>: localized reaction that replaces normal tissues. Epithelioid and giant cells present. Necrosis +/-. Causes: delayed hypersensitivity, foreign material, TB, fungus, syphilis, sutures</li>
  <li><strong>Granuloma</strong>: macrophages fuse, forming giant cells. Mediated by IL-4 secreted by T<sub>H</sub>2 cells. Causes E-cadherin surface expression. Collagen!</li>
  <li>Inflammation is a series of overlapping steps!</li>
</ul>

<div style="text-align:center;">
  <p><img src="/assets/inflammation-overlapping-processes.png" alt="" /></p>
</div>

<p><span><br /></span></p>

<h3 id="inflammation---exudates">Inflammation - Exudates</h3>
<ul>
  <li><strong>Serous</strong>: watery, often just transudate. Example: bister</li>
  <li><strong>Effusion</strong>: serous fluid in a body cavity. Example: pleural effusion causing egophony</li>
  <li><strong>Catarrhal</strong>: water plus mucus. Example: rhinorrhea in the setting of viral upper respiratory process</li>
  <li><strong>Fibrinous</strong>: fibrin on surfaces. Example: pericarditis</li>
  <li><strong>Purulent</strong>: thick, cellular exudate. Example: abscess</li>
  <li><strong>Hemorrhagic</strong>: vascular involvement</li>
  <li><strong>Pseudomembranous</strong>: sheets of dead cells and PMNs. Example: pseudomembranous colitis is pathognomonic for C. Diff.</li>
</ul>

<p><span><br /></span></p>

<h3 id="lymphadenitis">Lymphadenitis</h3>
<ul>
  <li>Tissue is drained by lymphatic vessels to the lymph nodes</li>
  <li>Inflammation may be combination of inflammatory cells plus organisms!</li>
  <li>Lymph node may have hyperplasia of follicles</li>
  <li><strong>Net result</strong>: enlargement of lymph node, lymphadenopathy</li>
</ul>

<p><span><br /></span></p>

<h3 id="laboratory-evaluation-of-inflammation">Laboratory Evaluation of Inflammation</h3>
<ul>
  <li>Increased PMN concentration is called <strong>leukocytosis</strong>, mediated by TNF and IL-1 which leads to increased production and release from the bone marrow. </li>
  <li>Normal WBC is 5,000 - 11,000 cells/mm<sup>3</sup></li>
  <li>Get a WBC differential count if there is clinical suspicion for inflammation or if leukocytosis prsent</li>
  <li>Left shift: more immature cells (bandemia) than mature cells</li>
  <li><strong>Lymphocytic leukocytosis</strong>: signifies a chronic inflammatory process. (Consider viral disease, tuberculosis)</li>
  <li><strong>Eosinophilic leukocytosis</strong>: signifies parasitic infection or allergic reaction</li>
  <li><strong>ESR and CRP</strong>: see below</li>
  <li><strong>Procalcitonin (PCT)</strong>: rises in inflammation and bacterial infection </li>
</ul>

<p><span><br /></span></p>

<h3 id="acute-phase-reactants">Acute Phase Reactants</h3>
<ul>
  <li>Host of proteins rise in the serum in response to inflammation or injury</li>
  <li>Many of these proteins are made in the <strong>liver</strong>, some of them are opsonins.</li>
  <li>Include: <strong>fibrinogen, globulins, CRP, SAA</strong></li>
  <li>Quantify to monitor for resolution of inflammatory process or development of chronic inflammation</li>
  <li><strong>Erythrocyte Sedimentation Rate (ESR)</strong>: measures how far RBCs fall per hour. Normal range is up to 20mm/hr. Increased rate by fibrinogen or globulin in serum which would be seen in inflammatory processes due to stimulation of acute phase reactants. Decreased rate with anemias due to abnormal erythrocytes.</li>
  <li><strong>C-reactive protein (CRP)</strong>: increased hepatic production of CRP triggered by IL-6. Peak CRP in 4-6 hours after acute-phase stimulation, remains elevated but falls in 7 days. Quantify with immunoassay. Elevated CRP found in post-operative recovery, acute MI, infections, and inflammatory disease.</li>
</ul>

			</div>
			<br>
			<hr>
            <div class="footer">
			<h6><p><a href="/">&#60; Back</a></p></h6>
			</div>
           	<div class="contact">
                <p>
					<a href="http://bquarant.github.io/">bquarant.github.io</a> | 2014 
               </p>
              </div>
          </div>
        </div>

<!-- Track traffic on gaug.es-->
		<script type="text/javascript">
		  var _gauges = _gauges || [];
		  (function() {
		    var t   = document.createElement('script');
		    t.type  = 'text/javascript';
		    t.async = true;
		    t.id    = 'gauges-tracker';
		    t.setAttribute('data-site-id', '51f19a5df5a1f51079000024');
		    t.src = '//secure.gaug.es/track.js';
		    var s = document.getElementsByTagName('script')[0];
		    s.parentNode.insertBefore(t, s);
		  })();
		</script>
    </body>
</html>